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For many experiments hybrid mice obtained by crossing two inbred strains
are preferable to either of the contributory pure lines. The F1 hybrids, although
not homozygous, are uniform in genetic constitution, they manifest " hybrid
vigour," and reciprocal crosses permit the study of different maternal factors in
conjunction with the same genotype. Mammary tumours develop unexpectedly
and erratically in some hybrid and pure line mice supposedly deficient in the
maternal milk agent which, according to Bittner (1942) and others, co-operates
with oestrogenic stimulation and appropriate genetic constitution to evoke
mammary tumours in mice of " high cancer" strains. The mammary tumours
described in this paper developed In hybrid mice which were presumed deficient
in the milk agent. Several of the tumours were readily transplantable into
female but not into male mice of appropriate genetic constitution, and experi-
ments showed that hormones controlled the outcome of transplantation.MAMMARY TUMOURS IN HYBRID MICE
MATERIAL AND METHODS.
A breeding colony consisting of twelve C57 Black females and three R3 nmales
was established in September, 1945. The C57 Black strain has been maintained
in this laboratory by brother-sister matings since 1941 ; spontaneous mammary
tumours have not been recorded in the pedigreed stock. The R3 strain has been
similarly maintained since 1934, and Dmochowski and Gye (1943) recorded
mammary tumours in 83 per cent of breeding females at an average age of 8-5
months. The presumed deficiency of milk agent in the C57 mothers gave reason
to expect a low incidence of mammary tumours in the F, hybrids of the cross
C57 Black females x R3 males (designated, shortly, CR). Mammary tumours
developed, however, and their incidence was studied in F1 hybrids born between
January and July, 1946. During this period, litters wererecorded and the mice,
with few exceptions, were sexed and given identification marks at the time of
weaning. Some females were kept as virgins but most were subjected to forced
breeding, being continuously with males and deprived of their litters within
48 hours of birth. Some of the mice were used in fruitless experinients, par-
ticularly for intraperitoneal injections of small doses of methylcholanthrene or
for transplantation experiments. The remainder suffered no experimental
interference.
Tumours were registered serially as CR1, CR2, etc. Many were removed
surgically. Material so obtained as well as post-mortem material was transplanted
into F1 hybrids similar to those having the primary tumours, but mostly fronm a
different colony. Fragments of tumour were implanted subcutaneously in the
flank by means of a transplanting needle. In one experiment minced
tissue was injected, using a Bashford transplanting syringe. The mice used in
routine transplantations were usually siblings, but for some experiments two or
more litters were combined to provide requisite numbers ofeach sex. The growth
of tumours was recorded regularly on silhouette charts.
RESULTS.
I. Occurrence of tumours.
Nine out of 71 breeding females which survived more than 6 months developed
mammnary tumours, and 48 are alive without tumours. One virgin female out
of 22 which survived a similar period developed a tumour, and 21 are alive
withouit tumnouis. The ages of the surviving mice range from about 14 to 20
months. No new tumours have been observed during the past 6 months. Par-
ticulars ofthe tumours are summarized in Table I, where the tumour-bearing mice
are arranged in order of birth.
The distribution of the tumours suggests a strong familial factor in their
incidence. Each of the four female mice of Litter 46/3 developed a tumour, as
did each of the two in Litter 46/28. Two litters, 46/33 and 46/34 were mixed
before the mice were marked; consequently the mice bearing tumours CR4
and CR10 were possibly, but not certainly, sisters. Tumour CR6 developed
in the only female of Litter 46/35 which survived more than 6 months.
Table I shows the age of the mice when tumours were first observed. The
average tumour age was 35-8 weeks for the whole group and 33-7 weeks for the
breeding females, the latter figure being almost identical with that recorded by
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TABLE I.
Transplantation.
Tumour-age
Serial -No. Litter No. (weeks). CT
CR1 . 46/3 . 39 . + .
CR2 . 46/3 . 39 4-
CR3 . 46/3 . 44 + . One I.P. injection of
methylcholanthrene.
CR5 . 46/3 . 46 4 + . One I.P. injection of
methylcholanthrene.
CR9 . 46/6 . 55 .... . .... . Virgin. One I.P. injec-
tionofmethylcholan-
threne.
CR7 . 46/28 . 34 + .
CR8 . 46/28 . 28
CR4 . 46/33-34 . 15 + .
CRI0 . 46/33-34 . 26 . .... . .... .
CR6 46/35 24 + + Biopsy.
Dmochowski and Gye for R3 breeding females. The appearance of CR4 at the
early age of 15 weeks is noteworthy.
Tumours developed in three mice (CR3, CR5 and CR9) which had received
each one intraperitoneal injection of0-25 c.c. of a 0 5 per cent solution ofmethyl-
cholanthrene in sesame oil. It is improbable that the carcinogen induced or
accelerated tumours CR3 and CR5, for tumours CR1 and CR2 developed, without
carcinogen, in sibling mice at a somewhat earlier age. The effect ofthe carcinogen
on the growth oftumour CR9 in a virgin is conjectural. Tumour CR10 developed
in a- mouse bearing a slow-growing implant of tumour CR1. The remaining 6
tumour-bearing mice had not been subjected to experiment.
II. Characteriistcs of the tumourn8s.
The tumours were not grossly or microscopically different from the familiar
mammary tumours of " high-cancer " strains or of mice of mixed ancestry as
described by Cloudman (1941) and Dunn (1945). Eight tumours were removed
surgically from 4 mice and 6 recurred locally. Before death 7 of the 10
tumour-bearing mice had multiple tumours. Two tumours (CR4 and CR8)
regressed under observation, but soon recurred. Post-mortem examination
disclosed extensive intraperitoneal dissemination of CR1. Metastatic deposits
were not found. The histological structure of the tumours was unremarkable;
in particular, squamous differentiation was found, in a slight degiee, in only
one ofthe many sections examined.
Transplanted tumours were likewise unremarkable in growth and structure.
Secondary tumours were found in the lungs of mice bearing tumours CR1, CR3
and CR6. Some tumours exuded milky fluid on section and microscopical
examination.revealed pronounced secretory activity; otherwise the microscopical
appearances were not distinctive.
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III. Results of transplantation.
Eight tumours, from 7 mice, were transplanted into F1 hybrids. With
rare exceptions all the implants in female mice grew, but growth of 5 of the
tumours was inhibited or greatly retarded in male mice as indicated by the *
sign in Table I. Tumours CR1 and CR6 were examined most thoroughly, and
together they illustrate the varieties of behaviour of CR tumours.
The tumour CR1 was removed surgically from a mouse which subsequently
developed a recurrent tumour at the operation site and two new mammary
tumours elsewhere and when killed, 10 weeks after the biopsy, had extensive
growth of tumour in the abdominal cavity. The chart of the first transplanted
generation (Fig. 1) shows the pronounced delay of growth in males in comparison
with females. The tumour in one male was first detected 23 weeks after implan-
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FIG. 1.-Tumour CRI. First transplanted generation.
tation, andthe mouse survived a further 22 weeks before being killed with a large
tumour. The difference between males and females was even more pronounced
in subsequent passages (Fig. 2 and 4). In mice observed for 12 weeks after
implantation, tumours grew in one out of 16 males and in all of 18 females. Many
tumour-free males were killed after about 3 months, but amongst the few which
were kept longer under observation tumours appeared in three at 15, 18, and
22 weeks respectively after implantation. One male survives without tumour
after 26 weeks, and two after 21 weeks. The earliest tumour in a male was
observed after 9weeks, whereas all females had detectable tumourswithin 6weeks.
The disparity between males andfemales was consistent in every series ofimplants
and persists after 5 passages. It is probable that given sufficient time implants
of CR1 implants may grow almnost as frequently in males as in females; the
clear-cut difference is the pronounced and often extreme retardation ofgrowth in
males.
Tumour CR6 was removed surgically and implanted in 3 male and 3 female
siblings. Tumours grew in all the females but in none of the males which were
killed after 11 weeks. Two ofthe tumours in females were further transplanted
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and originated two sublines differing in behaviour. The first tumour grew in
each of 4 females, but not in one male, and in three subsequent passages
tumours developed in 7 out of 8 females and, tardily, in 1 out of 7 males after
observation for from 18 weeks in the earliest of the passages to 4 weeks in the
most recent. The second tumour grew in all of 4 males and 4 females and
behaved similarly in three subsequent passages, with a possible but inconspicuous
delay in some of the males.
The mouse from which CR6 was removed lived a further 18 weeks and was
then killed bearing two new tumours. The larger tumour, designated CR6B,
was transplanted, and in three passages grew in all males as well as females with
inconspicuous differences in rate. This tumour and, to a less degree, the second
subline of CR6 grew more vigorously than did the more discriminating subline
of CR6.
Five other CR tumours were examined in less detail. Four tumours were
transplanted through only two passages and the limited observations showed
that two (CR2 and CR7) resembled CR1, growing in females, and tardily or not
at all in males, and two (CR3 and CR5) resembled CR6B growing with comparable
vigour in males and females. Transplantation of the remaining tumour CR4 is
being maintained, and up to the third passage it has resembled CR1.
A sex factor in transplantation was thus observed with five CR tumours but
was inapparent with three others. It was investigated in experiments mainly
with the CR1 tumour, which behaved most consistently. The possible interven-
tion of a genetic factor or of the milk agent was investigated by implantations
into reciprocal hybrids, and the more probable influence ofhormones by implants
in castrated males, oestrogenized males, and ovariectomized females.
Implants in reciprocal hybrids.
The tumours developed in F1 hybrids of the cross C57 Black females x R3
males (CR) and similar CR hybrids were used for the routine transplantations.
The females ofthe reciprocal cross, R3 females x C57 Black males (RC), havethe
same genetic constitution as CR females, but the males differ in their Y chromo-
somes, which derive from the R3 parent in CR males and from the C57 Black
parent in RC males. The RC mice obtain milk containing the milk agent from
their R3 mothers, whereas a supply of the agent from C57 Black mothers to the
CR hybrids is uncertain.
Implants of CR1 behaved in three groups of RC siblings as in the routine
transplantations. In the first group tumours grew in each of 3 females,
but in none of 4 male siblings during observation for 13 weeks, in the second
group in each of 2 females, but not in one male sibling during 11 weeks, and in
the third group in each of 2 females, but none of 3 male siblings during
11 weeks.
Implants in castrated male mice.
Pairs of CR male litter-mates were selected from two litters of CR mice;
one of each pair was castrated, the other being left as an intact control. Two
weeks after operation CR1 tumour was implanted in castrated and intact males
as well as in normal female litter-mates. Tumours developed, characteristically,
in each of 3 females, and after long delay in one of 3 intact males, but in
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none of the three castrated males, during observation for 20 weeks (Fig. 2).
In an experiment to which further reference is made in the section which follows,
5 intact males and 5 castrated males were free from tumour 11 weeks after
implantation of CR1. Implants of a subline of tumour CR6 grew in each of
4 intact males and in 2 of 4 castrated males. Castration, therefore, did not
enhance the growth of CR tumours in male mice, but possibly increased the
usual inhibition.
Intact _ _ _ _ _ .
Castrate
cir
Normal - * ? p 9 t
Weeks 2 46 8 1 14 1 2
Weeks 2 4 6 t3 10 12 14 16 IS 20 ,5cm.,
FIG. 2.-Tumour CR1. Third transplanted generation. Castration 14 days before implantation
of tumour.
Implants in oestrogenized males.
Cholesterol pellets containing 25 per cent diethylstilboestrol (B.D.H.) and
weighing 5-7 mg. were implanted subcutaneously in male CR mice, and normal
male and female litter mates were set aside as controls. Tumour CR1 was
implanted 6 days after the pellets and grew promptly in the oestrogenized
males, the rate ofgrowth being comparable with that in normal females (Fig. 3).
Implants of CR1 grew similarly in 11 out of 12 males, aged about 14 months, in
which stilboestrol pellets were implanted 15 days previously but not in 3
normal males of similar age. In another experiment with mice 'aged about
14 months, tumour CR1 vwas implanted in 10 intactmales and 10 castratedmales;
5 of the intact and 5 of the castrated -mice carried stilboestrol pellets inserted
15 days previously. All the oestrogenized mice developed tumours in 5-6 weeks,
whereas all the mice without oestrogen pellets were free from tumours after
11 weeks, up to which time there'was no appreciable difference between intact
and castrated mice.
Tumour CR4 was used in one experiment and behaved like CR1, growing in
oestrogenized males and normal females, but not in normal males of the same
litter.
Implants in ovariectomizedfemales.
Fig. 4 shows the result of implanting CR1 tumour in 6 litter mates com-
prising 2 intact females, 2 females ovariectomized 20 days previously, and
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2 intact males. ::Inhibition of growth in the ovariectomized females is
apparent, though less complete than in intact males. In a similar experiment
with RC mice, 2 ovariectomized females and 1 male were free from tumour
after 11 weeks, whereas 2 intact females developed tumours within 4 weeks.
Normal _ - _ _ . . .
__ ._ - - - - - 6
_g # w 1
0
Oestrofien
FIG. 3.-Tumour CR1.
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Fourth transplanted generation. Stilboestrol pellets implanted
6 days before imnplantation of tumour.
Normal c
Norimal
Ovariectomised -
Weeks 3 5 7 9 11
FIG. 4.-Tumour CR1. Fifth transplanted generation. Ovariectomy 20 days before implan-
tation of tumour,
Minced CR1 tumourin a dose of0-02 c.c. was injectedsubcutaneously into a litter
comprising 2 ovariectomized females, 2 intact females, and 3 males. Tumours
developed in ovariectomized as well. as in intact females and also, within
5 weeks, in 2 of the males. Apparently the large inoculum was less dependent
on hormones than the fragments implanlted in the other experiments.
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DISCUSSION.
The experiments show that hormones regulate the growth of implants of
certain CR tumours in hybrid mice which are similar in genetic constitution to
those in which the tumours originate. Genetic relationships usually predominate
amongst the factors which determine the outcome of tumour transplantation,
but, as Loeb (1945) maintains, they are not the only operative factors and they
are not always decisive. The resistance to transplantable tumours, as studied
intensively in mice of mixed ancestry, depends on genetic differences between
implant and host; it is ineffective against tumours growing in their original
hosts or transplanted into other animals of similar genetic constitution, and it
does not account for the inhibition of CR tumours in male CR mice.
Many CR implants grow in male mice after long dormancy; possibly all will
do so, given sufficient time. The inhibition in these males is not accountable to
inhibition of the " take " with consequent destruction of the implant, but to a
prolongation of the latent period which precedes manifest growth. Castration
does not promote the growth of implants in males, whereas administration of
stilboestrol enables tumours to grow as well in males as in females. Ovari-
ectomy, in the experiments so far completed, is less decisive, but is plainly
unfavourable to the growth of implants. Together, the experiments disclose
the absence from normal males, and the presence in normal females, of a stimulus
which is necessary for the prompt growth of CR implants. Administration of
stilboestrol provides an adequate stimulus for growth in males.
The sex difference in the transplantation of CR1 tumours has been consistent
through five generations of transplantation. Observations on the CR6 tumours,
however, show that the dependence on the hormone stimulus is sometimes lost
after transplantation, and though conspicuous in one primary tumour, it may be
inapparent in another tumour developing later in the same animal. The per-
manence and, probably, the degree ofhormone-dependence differfrom one tumour
to another, even when the tumours originate inthe same animal. It is conceivable
that many or all mammary tumours of mice pass through a phase of hormone-
responsiveness which is transitory and rarely detected, but Woglom (1913),
reviewing the earlier exhaustive work on transplantation of mammary tumours
in mice of mixed ancestry, states that " No observer has yet discovered any
difference in susceptibility between males and females . . .", and the same
conclusion seems applicable to the more recent experiments using inbred mice.
The CR tumours are exceptional in the existence or protraction of a hormone-
sensitive phase. This exceptional property possibly, but not certainly, depends
on the operation of unusual aetiological factors. Andervont (194 ) provides
several possible explanations for the sporadic occurrence ofmammary tumours in
" low-cancer " lines and hybrids presumed deficient in the milk agent; experi-
mental evidence for one or the other is lacking. The strong familial factor in
the incidence of CR tumours is under investigation. Meanwhile it is noteworthy
that the CR tumours do not correspond with those mammary tumours which
develop in mice deficient in the milk agent and which, according to Gardner
(1947), appear at an advanced age, grow slowly, and are oftfen of squamous cell
type. The distinctive properties of CR tumours are revealed only by transplan-
tation.
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A comparable dependence on hormones is manifested by transplantable
fibroadenoma of the breast in rats (e.g. Heiman and Krehbiel, 1936) arid, in mice,
by certain tumours oftestis, ovary and hypophysis induced, mostly, by prolonged
administration of oestrogen (Gardner, 1947). The CR tumours have several
special features: they develop naturally; their aetiology is possibly unusual;
they resemble the most intensively studied of animal tumours-the mammary
tumours of mice of mixed ancestry and of inbred strains-except for the sex-
difference in transplantation; they show that responsiveness to hormones is not
inconsistent with " malignancy " as judged by the usual clinical and pathological
criteria, and that responsiveness may be a temporary property characterizing
.one stage in the progression of a malignant tumour.
SUMMARY.
Mammary tumours were observed in hybrid mice obtained by crossing
low-cancer " strain C57 Black females and " high-cancer " strain R3 males;
a low incidence ofmammary tumours was anticipated on account ofthe presumed
deficiency of milk agent in C57 Black females. A familial factor in the origin of
the tumours was apparent and is under further investigation. The tumours, in
structure and behaviour, resembled the familiar mammary tumours of mice,
except that the growth of transplants of some of them was inhibited in male
hosts. The inhibition, due to prolongation ofthe latent period preceding manifest
growth, was annulled by administration of an oestrogen, but not by castration.
Ovariectomy was unfavourable to growth in females. It was concluded that
the growth of implants depended on a hormonal stimulus provided by normal
females but not by normal males. A dependence on hormones was sometimes
maintained through several transplanted generations, was sometimes. lost in the
course of transplantation, and sometimes inapparent at the first examination
of a primary tumour.
It is possible that dependence on hormones characterizes one phase in the
progression ofmalignant mammary tumours inmice, thisphase, usually transitory
and difficult to detect, beingexceptionallyprolonged inthetumours here described.
As yet there is no evidence to show whether or not the exceptional property is
due to unusual aetiological factors.
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